Attached files
| file | filename |
|---|---|
| EX-23.1 - EXHIBIT 23.1 - Brooklyn ImmunoTherapeutics, Inc. | nt10023650x4_ex23-1.htm |
| EX-5.1 - EXHIBIT 5.1 - Brooklyn ImmunoTherapeutics, Inc. | nt10023650x4_ex5-1.htm |
| S-1 - S-1 - Brooklyn ImmunoTherapeutics, Inc. | nt10023650x4_s1.htm |
Exhibit 23.2
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We consent to the incorporation by reference in this Registration Statement of Brooklyn ImmunoTherapeutics, Inc. on Form S-1 of our report dated April 30, 2021, with respect
to our audits of the financial statements of Brooklyn ImmunoTherapeutics, LLC as of December 31, 2020 and 2019 and for each of the two years in the period ended December 31, 2020 appearing in Amendment No. 1 to Form 8-K/A of Brooklyn
ImmunoTherapeutics, Inc. dated April 30, 2021. We also consent to the reference to our firm under the heading “Experts” in the Prospectus, which is part of this
Registration Statement.
/s/ Marcum llp
Marcum llp
New York, NY
May 27, 2021